Comments on "The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020"

Int J Cancer. 2023 Oct 1;153(7):1423-1424. doi: 10.1002/ijc.34627. Epub 2023 Jul 8.

Authors

Anders K M Jakobsen¹, Karen-Lise Garm Spindler²

Affiliations

¹ Department of Oncology, Vejle University Hospital, Institute of Regional Health Services, University of Southern Denmark, Vejle Hospital, Vejle, Denmark.
² Experimental Clinical Oncology, Department of Oncology, Aarhus University Hospital, Aarhus University, Aarhus N, Denmark.

PMID: 37421183
DOI: 10.1002/ijc.34627

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Approval
Humans
Neoplasms* / drug therapy
United States
United States Food and Drug Administration